Advertisement

BMC Geriatrics

, 18:236 | Cite as

Disability, quality of life and all-cause mortality in older Mexican adults: association with multimorbidity and frailty

  • Ana Rivera-Almaraz
  • Betty Manrique-Espinoza
  • José Alberto Ávila-Funes
  • Somnath Chatterji
  • Nirmala Naidoo
  • Paul Kowal
  • Aarón Salinas-Rodríguez
Open Access
Research article
Part of the following topical collections:
  1. Public health, nutrition and epidemiology

Abstract

Background

Multimorbidity and frailty are relevant conditions among older adult population. There is growing evidence about their association with poor health outcomes like disability, worst quality of life, and death. Nonetheless, the independent associations of both conditions have been studied, and few evidence exists about an interaction between them. Our aims were to assess the association of frailty and multimorbidity with the disability, quality of life and all-cause mortality as well as to analyze a potential interaction between these conditions.

Methods

Analytical samples included 1410 respondents for disability and quality of life, and 1792 for mortality. We performed a longitudinal analysis with older Mexican adults aged 50, using data collected from the WHO’s Study on global AGEing and Adult Health Waves 1 and 2. Disability was measured using the World Health Organization Disability Assessment Schedule (WHODAS 2.0), and quality of life using the WHOQOL (WHO Quality of Life) instrument. All-cause mortality was determined by reviewing death certificates. Associations of frailty and multimorbidity with disability, quality of life and mortality were estimated using linear regression and Cox proportional hazards models.

Results

Multimorbidity assessed through three patterns (cardiopulmonary, vascular-metabolic, and mental-musculoskeletal) was associated with the three outcomes in this study. Cardiopulmonary and mental-musculoskeletal patterns increased the WHODAS mean score (β = 5.05; p < 0.01 and β = 5.10; p < 0.01, respectively) and decreased WHOQOL score (β = − 1.81; p < 0.01 and β = − 2.99; p < 0.01, respectively). Vascular-metabolic was associated with mortality (HR = 1.47; p = 0.04), disability (β = 3.27; p < 0.01) and quality of life (β = − 1.30; p = 0.02). Frailty was associated with mortality (pre-frail: HR = 1.48; p = 0.02 and frail: HR = 1.68; p = 0.03), disability (pre-frail: β = 5.02; p < 0.01; frail: β = 13.29; p < 0.01) and quality of life (pre-frail: β = − 2.23; p < 0.01; frail: β = − 4.38; p < 0.01). Interaction terms of frailty and multimorbidity were not statistically significant.

Conclusions

Multimorbidity and frailty are important predictors of poor health outcomes. These results highlight the importance of carrying out health promotion and prevention actions as well as specific interventions aimed at older adults who suffer from multimorbidity and frailty, in such a way that deleterious effects on health can be avoided.

Keywords

Multimorbidity Frailty Mortality Disability Quality of life Older adults 

Abbreviations

ADL

Basic activities of daily life

BMI

Body mass index

CDs

Chronic diseases

CES-D

Center for Epidemiologic Studies Depression Scale

CI

Confidence Interval

COPD

Chronic obstructive pulmonary disease

DSM IV

Diagnostic and Statistical Manual of Mental Disorders

GPAQ

Global Physical Activity Questionnaire

HR

Hazard Ratio

IADL

Instrumental activities of daily life

ICD-10

International Statistical Classification of Diseases and Related Health Problems

MHAS

Mexican Health and Aging Study

NS

Not Statistically significant

OA

Older adults

SAGE

Study on global AGEing and adult health

SF-36

36-Item Short Form Health Survey

WHO WMH-CIDI

World Health Organization World Mental Health Composite International Diagnostic Interview

WHO

World Health Organization

WHODAS 2.0

World Health Organization Disability Assessment Schedule 2.0

WHOQOL

WHO Quality of Life

β

Beta Coefficient

Background

The proportion of the world’s population aged 60 and older is increasing rapidly. Within 35 years, it will have spiraled from 12% (in 2015) to 22% (in 2050). Virtually all the regions in the world are witnessing this population aging process [1]. From a public health perspective, older adults (OA) account for 23% of the global burden of disease, particularly as regards chronic diseases (CDs) such as cardiovascular, pulmonary, musculoskeletal, neurological, mental, and neoplastic conditions [2]. They have also been found to be at higher risk for multimorbidity and geriatric syndromes such as frailty [3].

Regarding multimorbidity, associations with greater use of health-care services and adverse health events such as polypharmacy, increased health expenditures, disability, a low quality of life, and even mortality have been reported [4, 5, 6]. However, multimorbidity research has traditionally focused on counting diseases, thus hindering the detection of co-occurrences. Notwithstanding, recent literature has highlighted the importance of taking into account the CDs combinations in OA health studies [7].

Frailty, on the other hand, defined as a biological syndrome resulting from cumulative declines across multiple physiologic systems, with impaired homeostatic reserve and a reduced capacity of the organism to withstand stress [8], has been identified as an independent predictor for adverse health outcomes including falls, a diminished quality of life, disability and death [9, 10, 11, 12, 13, 14].

Although OA can suffer from multimorbidity and frailty simultaneously, a causal link has been suggested between them [15], empirical evidence has focused on the independent effects that they have on adverse health outcomes. Among the scarce evidence that has explored the joint effects of multimorbidity and frailty, one study with OA residents of Hong Kong found that combination of frailty and multimorbidity increased the risk of disability and death [16]. However, it is still pending to analyze this interaction effect on other outcomes such as health-related quality of life. Therefore, our main aim in this study was to estimate the independent associations of multimorbidity and frailty with three different outcomes: disability, quality of life and all-cause mortality. A secondary aim was to determine whether exist a significant interaction effect of the multimorbidity and frailty on those same outcomes.

Methods

Study design

We drew our data from the Study on global AGEing and adult health (SAGE), a longitudinal, multicenter study conducted by the World Health Organization (WHO) across six low- and middle-income countries: India, Ghana, Russia, Mexico, South Africa and China [17]. Based on a multistage, stratified and cluster design, SAGE provided nationally representative groups of adults aged 50 and older, disaggregated by rural/urban strata. It applied standardized instruments including household and individual-level questionnaires, as well as anthropometric and functionality measurements. The present study consisted of a longitudinal analysis of SAGE-Mexico data derived from the two measurements available to date (2009 and 2014).

Study sample

Baseline measurement

In 2009, Wave 1 performed baseline measurements with a sample size of 2306 adults aged 50 years and older and a smaller comparison group of 436 subjects aged 18–49 years.

Follow-up

The first follow-up (Wave 2), conducted in 2014, included all eligible subjects from Wave 1. In addition, the sample was refreshed with a sample of both age groups: one from 18 to 49 years, the other 50 years and older. A total response rate of 83.47% was achieved. Full interviews were administered to a larger number of participants than in Wave 1: 853 aged 18–49 years, and 4301 aged 50 and older.

Our analytical sample included Wave 1 respondents aged 50 and older as well as Wave 2 subjects who provided information on the variables of interest. Of the 2306 OA in Wave 1, 1595 were interviewed and 273 had died (14.61%). The remaining 438 (19%) either declined our invitation to participate in the study or were not located. Analytical samples of OA aged 50 and older included 1410 respondents for disability and quality of life, and 1792 for mortality (Fig. 1).
Fig. 1

Population study and analytical sample

Outcomes. We analyzed three of the Wave 2 outcomes: disability, quality of life and all-cause mortality.

Disability

We measured this variable according to the World Health Organization Disability Assessment Schedule (WHODAS 2.0) [18]. The WHODAS 2.0 scale is widely used to measure last-month limitations in activity and daily-life participation. It covers six domains explored through a total of 12 items (two per domain): (1) cognition and communication, (2) self-care, (3) mobility, (4) interpersonal relations, (5) life activities, and (6) participation. The results of the 12 items are summed up to obtain a global score expressed on a continuous scale from 0 (no disability) to 100 (full disability) [18].

Quality of life

For this variable, we used the WHOQOL (WHO Quality of Life) instrument. This eight-item questionnaire covers the following core domains (two items per domain): physical, psychological, social and environmental. The results of the eight items are added up to obtain an overall WHOQOL score expressed on a scale from 0 to 100. The higher the score, the higher the quality of life [19].

All-cause mortality

Data drawn from the Wave 2 interviews (2014) included information about death (for any cause) occurred between Waves 1 and 2 using a verbal autopsy. We recorded the date of death, which provided information on the interval between baseline and death.

Exposures

Multimorbidity

We used a nine CDs list that was included in the SAGE study. Three were measured according to self-reported medical diagnoses: diabetes, stroke, and cataracts. Five were estimated through algorithms for symptomatology and self-reported treatment: angina, arthritis, chronic obstructive pulmonary disease, asthma, and depression [20]. Finally, hypertension was determined by either blood pressure measurement and/or self-reported treatment. The CDs were assessed dichotomously (1 = presence, 0 = absence).

Frailty

For this variable, we used the frailty phenotype proposed by Fried et al. (2001), which covers five components: unintended weight loss, exhaustion, low physical activity, slow walking speed and weakness. Subjects considered frail presented three or more of these components; pre-frail one or two; and not frail, or robust, none. The results were thus expressed categorically: 0 = not frail, 1 = pre-frail, and 2 = frail [8]. Frailty components were assessed as follows:
  1. (1)

    Unintended weight loss during the past year was determined according to a self-reported reduction of five kilograms or more in the past 12 months. Subjects with this condition were considered frail based on weight loss.

     
  2. (2)

    Exhaustion was assessed according to a question from the World Health Organization World Mental Health Composite International Diagnostic Interview (WHO WMH-CIDI). The question took into account the definition and criteria for “depressive episode” diagnosis as specified in the International Statistical Classification of Diseases and Related Health Problems (ICD-10) and in the Diagnostic and Statistical Manual of Mental Disorders (DSM IV). It was used as a proxy for the depression-scale questions in the Center for Epidemiologic Studies Depression Scale (CES-D) used by Fried et al. in their definition of exhaustion. Subjects were specifically asked, “During the last 12 months, have you had a period lasting several days when you have been feeling your energy decreased or that you are tired all the time?” Those who gave a positive response were considered frail based on exhaustion.

     
  3. (3)

    Low physical activity was determined according to the Global Physical Activity Questionnaire (GPAQ). It was measured by estimating the weekly caloric expenditure of respondents, stratified by sex. Those who fell within the fifth lowest percentile of weekly kilocalories, by sex, were considered frail based on physical activity.

     
  4. (4)

    Slow walking speed was determined according to the time (seconds) it took participants to walk a distance of four meters at normal speed. Slow walking speed corresponded to a time span equal to or greater than the 80th percentile (in seconds), stratified by sex and median height.

     
  5. (5)

    Weakness was measured with a dynamometer. Results were stratified by sex and quartiles of body mass index (BMI). We first considered maximum grip strength values, and then obtained quintiles for each BMI quartile. Low grip strength was equivalent to the lowest quintile in each BMI quartile by sex.

     

Covariates

Using the literature on factors associated with older adults’ mortality and disability as a guide, risk factors were selected as potential covariates and then identified in the SAGE dataset. Covariates were categorized as follows: age, sex (1 = female), education (years of schooling), marital status (1 = with partner), place of residence (1 = rural), and household income using a continuous index based on household assets, where higher positive values indicated higher incomes.

Statistical analysis

We used bivariate analyses to examine the relationships between the independent variables (frailty and multimorbidity patterns) and the dependent variables (disability, quality of life and mortality). We employed the following tests: Chi-square for categorical variables and ANOVA or Kruskall-Wallis for continuous variables.

Multimorbidity patterns

As we were interested in the CDs combinations more than a simple count of them, we performed a principal-components analysis of the nine CDs mentioned above to identify possible multimorbidity patterns. Given that the CDs were coded dichotomously, we built a polychoric correlation matrix, with the optimal number of patterns (components) determined according to the rule of eigenvalues greater than one. Then each CD was assigned to the component where its coefficient yielded the highest factor loading (score).

Disability and quality of life

To assess the relationships of the multimorbidity patterns and frailty with (1) disability and (2) quality of life, we applied linear regression models.

Mortality

To analyze mortality, we explored participant survival time based on the Cox proportional hazards model. We performed exploratory analysis by estimating Kaplan-Meier curves for all categorical predictors, and log-rank test for equality of strata to assess the predictors in the final model. We selected model predictors according to the exploratory analysis and prior evidence on OA survival.

Finally, we assessed the interaction effects between frailty and each multimorbidity patterns. We tested the statistical significance of this potential interaction effect by including a multiplicative term between frailty and multimorbidity patterns into the three regression models.

Data were weighted using post-stratified individual probability weights based on the selection probability at each stage of selection. Differences were considered statistically significant if p < 0.05. All statistical analyses were performed using STATA version 15.1 software (StataCorp. 2017. College Station, TX.).

Results

Baseline characteristics

Table 1 presents the distribution of the study variables at baseline. Mean scores for WHODAS 2.0 and WHOQOL were 15.7 (SD = 16.3) and 47.4 (SD = 11.8) respectively. Meanwhile, prevalence rates for multimorbidity patterns were: 14.5% for cardiopulmonary, 68.3% for vascular-metabolic, and 21.5% for mental-musculoskeletal. Frailty prevalence was 7.9% and for pre-frailty was 58.0%.
Table 1

Baseline health and socio-demographic characteristics

 

Mean/Percentage

S.D.

Outcomes

 Disability (WHODAS 2.0)a

15.7

16.3

 Quality of life (WHOQOL)b

47.4

11.8

Main exposure variables

 Multimorbidity

34.5

 

Multimorbidity patterns

 Pattern 1: Cardiopulmonaryc

14.5

 

 Pattern 2: Vascular-metabolicd

68.3

 

 Pattern 3: Mental-musculoskeletale

21.5

 

Frailty

 Nonfrail

34.1

 

 Prefrail

58.0

 

 Frail

7.9

 

Covariates

 Age (years)

63.0

10.6

 Female

53.2

 

 Marital status (with partner)

73.0

 

 Education (years)

5.0

4.5

 Residence (rural)

21.2

 

 Income

0.09

0.41

aWHODAS 2.0 (0 = no disability, 100 = total disability); bWHOQOL (0 = worst quality of life, 100 = best quality of life); cPattern 1: chronic obstructive pulmonary disease, asthma and angina; dPattern 2: diabetes, hypertension, stroke and cataracts; ePattern 3: arthritis and depression

Multimorbidity patterns

We identified three multimorbidity patterns that explained 55% of the variance among the nine CDs analyzed. Pattern 1, cardiopulmonary conditions, included angina, chronic obstructive pulmonary disease, and asthma; Pattern 2, metabolic-vascular conditions, included diabetes, arterial hypertension, stroke and cataracts; and Pattern 3, mental-musculoskeletal conditions, included arthritis and depression (see Additional file 1: Figure S1 and Table S1).

Table 2 displays the bivariate associations of frailty and multimorbidity with disability, quality of life and all-cause mortality.
Table 2

Bivariate associations of frailty and multimorbidity with disability, quality of life and all-cause mortality

Main exposure variables

Disability (WHODAS 2.0)a n = 1410

Quality of life (WHOQOL)b n = 1410

Mortality n = 1792

Mean

p value

Mean

p value

Percentage

p value

Frailty

 Nonfrail

8.7

< 0.001

56

< 0.001

4.3

< 0.001

 Prefrail

19.4

51.1

10.2

Frail

26.1

51.5

29.6

Multimorbidity patterns

Pattern 1: Cardiopulmonaryc

  Presence

20.9

< 0.001

50.2

< 0.001

10.4

0.966

  Absence

14.6

53.5

9.7

Pattern 2: Vascular-metabolicd

 Presence

14.8

< 0.001

53.4

0.004

12.8

< 0.001

 Absence

16.8

52.2

3.6

Pattern 3: Mental-musculoskeletale

 Presence

21.9

< 0.001

46

< 0.001

6.5

0.751

 Absence

13.6

55.1

10.8

aWHODAS 2.0 (0 = no disability, 100 = total disability); bWHOQOL (0 = worst quality of life, 100 = best quality of life); cPattern 1: chronic obstructive pulmonary disease, asthma and angina; dPattern 2: diabetes, hypertension, stroke and cataracts; ePattern 3: arthritis and depression

Disability

The presence of frailty was associated with disability, pre-frail and frail subjects indicating a higher average WHODAS score (p < 0.001). As regards multimorbidity patterns, cardiopulmonary conditions (p < 0.001) and mental-musculoskeletal conditions (p < 0.001) were also associated with greater disability.

Quality of life

Lower quality of life was observed in pre-frail and frail subjects (p < 0.001). Furthermore, the presence cardiopulmonary conditions (p < 0.001) or mental-musculoskeletal conditions (p < 0.001) was associated with lower WHOQOL scores.

Mortality

Mortality was greater among frail (29.6%) and pre-frail (10.2%) OA as compared to those who were not frail (4.3%) (p < 0.001). Those exhibiting metabolic-vascular conditions had a higher mortality rate in comparison with those not suffering from these conditions: 12.8% versus 3.6% (< 0.001).

Table 3 shows the results of three regression models used to estimate the association between our main exposures (frailty and multimorbidity) and the three outcomes: disability, quality of life, and mortality.
Table 3

Adjusted associations of frailty and multimorbidity with disability, quality of life and all-cause mortality

 

Model 1

Disability (WHODAS 2.0)a

Model 2

Quality of life (WHOQOL)b

Model 3

Mortality

β

(95% CI)

β

(95% CI)

HR

(95% CI)

Frailty

 Nonfrail

Reference

 

Reference

 

Reference

 

 Prefrail

5.02

(3.24,6.80)*

−2.23

(−3.23,-1.24)*

1.48

(1.05,2.09)*

 Frail

13.29

(9.81,16.78)*

−4.38

(−6.32,-2.43)*

1.68

(1.06,2.68)*

Multimorbidity patterns

 Pattern 1: Cardiopulmonaryc

5.05

(2.86,7.25)*

−1.81

(−3.04,-0.58)*

0.82

(0.58,1.14)

 Pattern 2: Vascular-metabolicd

3.27

(1.40,5.13)*

−1.3

(−2.34,-0.26)*

1.47

(1.03,2.10)*

 Pattern 3: Mental-musculoskeletale

5.1

(2.98,7.22)*

−2.99

(−4.17,-1.81)*

0.72

(0.52,1.01)

*p < 0.05; β: beta coefficient; HR: hazard ratio; CI: confidence interval. aWHODAS 2.0 (0 = no disability, 100 = total disability); bWHOQOL (0 = worst quality of life, 100 = best quality of life). cPattern 1: chronic obstructive pulmonary disease, asthma and angina; dPattern 2: diabetes, hypertension, stroke and cataracts; ePattern 3: arthritis and depression. All models were adjusted for age, sex, marital status, education (years), residence, and household income; only the Cox proportional model for mortality risk was adjusted for these variables plus disability (WHODAS 2.0 score)

Regarding disability, the results showed that pre-frailty and frailty increased the level of disability. Compared to non-frail, WHODAS score increased five points among pre-frail (β = 5.02; 95% CI 3.24; 6.80), and 13 points for frails individuals (β = 13.29; 95% CI 9.81; 16.78). For multimorbidity patterns, OA with cardiopulmonary and mental-musculoskeletal conditions had an increase in WHODAS scores (β = 5.05, and β = 5.10, respectively) and those with vascular-metabolic conditions had a slightly minor increase (β = 3.27) (Model 1).

For the quality of life, pre-frail and frail individuals had lowest scores in WHOQOL than non-frail subjects (β = − 2.2, and β = − 4.3, respectively). Similarly, the three morbidity patterns diminished the mean WHOQOL scores. Musculoskeletal conditions had the greatest effect (β = − 2.99; 95% IC -4.17;-1.81), meanwhile cardiopulmonary conditions (β = − 1.81, 95% CI -3.04,-0.58), and vascular-metabolic conditions (β = − 1.30, 95% CI -2.34,-0.26) had a moderately minor impact (Model 2).

Related to mortality, results of the Cox models showed that pre-frail OA had a risk of death 48% higher than that non-frail (HR = 1.48; 95% CI 1.05; 2.09), and for the frail subjects that risk was 68% higher (HR = 1.68; 95% CI 1.06; 2.68). For the three morbidity patterns analyzed, only vascular-metabolic condition was associated with an increased risk of death (HR = 1.47; 95% CI 1.03; 2.10) (Model 3). Figure 2 depicts graphically the results of the Cox models for our two exposures, frailty and multimorbidity patterns.
Fig. 2

Survival function for the Cox proportional hazard regression by (a) frailty categories (b) cardiopulmonary pattern; (c) vascular-metabolic pattern; and (d) mental-musculoskeletal pattern

Finally, results showed that none interaction term (between frailty and multimorbidity patterns) proved statistically significant (see Additional file 2: Table S2).

Discussion

The results of this study show that frailty and multimorbidity were independently associated with the disability, quality of life and mortality after 5-years follow-up among a national sample of older Mexican adults. Frailty and multimorbidity rose the mean scores of the WHODAS and WHOQOL and also increased the risk of death. However, no significant interactions between frailty and multimorbidity were found.

Our study identified three multimorbidity patterns in Mexican OA, which were: cardiopulmonary, vascular-metabolic and mental-musculoskeletal. The evidence related to multimorbidity patterns has led us to conclude that these patterns are composed of diseases sharing a number of similarities from a clinical perspective.

Regarding the first pattern, cardiopulmonary condition, comprised of asthma, chronic obstructive pulmonary disease (COPD), and angina, a clinical and molecular link had been previously established [21, 22]. For the second pattern identified, vascular-metabolic conditions, evidence support the relationship between metabolic syndrome (chronic inflammation, adiposity, etc.) and aging. This pattern includes CDs such as diabetes, arterial hypertension, stroke and cataracts [23, 24]. Finally, the third pattern, comprising arthritis and depression (mental-musculoskeletal), can be explained by the link reported several decades ago between pain and mental illness, which suggests that they share a number of biological pathways [25, 26, 27].

Our findings indicate that the three multimorbidity patterns analyzed were independent predictors for increased disability among OA. These results are consistent with the studies that have analyzed this link taking multimorbidity patterns into account. Jackson et al. (2015) studied a cohort of older Australian women and found that patterns similar to mental-neurological and cardiopulmonary conditions were associated with higher levels of disability (measured by the basic and instrumental activities of daily life - ADL and IADL, respectively) [28]. Furthermore, Arokiasamy et al. reported an association between diabetes and hypertension combination and the presence of disability (+ 1 ADL) in adults 18 and older [5]. Otiniano et al. (2003) found that the combination of diabetes and stroke increased the risk of disability (1 + ADL and 1+ IADL) in Mexican-American OA aged 65 and older, at five-year follow-up [29]. Quinones et al. (2016) reported that the combination of arthritis, depression and hypertension in American OA was associated with higher levels of disability (combined ADL and IADL index) at two-year follow-up [30].

Frailty was also an independent predictor for disability. This finding is also consistent with those reported in the literature [9, 31], even allowing for different follow-up periods [8, 10, 32, 33]. In the Mexican context, at 11-year follow-up, the cohort of OA aged 60 years and older from the Mexican Health and Aging Study (MHAS) indicated that frailty was a predictor for disability as regards ADL, but not IADL, while pre-frailty was a predictor only for restricted mobility, but not for ADL or IADL [9]. Another study of urban OA aged 70 and older in the Mexican Coyoacan Cohort Study found that frailty increased ADL and IADL disability [31].

In our study disability was measured using the WHODAS 2.0, which traditionally has been done using ADL and IADL criteria in older adult population. The use of WHODAS allowed that functionality spectrum of OA was enhanced [34]. This means that vulnerability resulting from frailty in OA could affect other spheres beyond the physical dimension, inter alia, their interaction with others and their participation in society.

We also found that frailty and multimorbidity diminished the quality of life as measured in the follow-up study. These results are consistent with those of Arokiasamy et al., who reported that the combination of asthma and hypertension correlated with a diminished quality of life in adults aged 18 and older [5]. Moreover there is evidence that depression among OA is independently associated with a lower quality of life [35], and that adults with arthritis have a particularly high probability of suffering from a deteriorated quality of life [36].

Our results indicate that baseline frailty status were an independent predictor for a deteriorated quality of life in the follow-up. There is scarce longitudinal evidence of an association between frailty and quality of life [13, 37]. Even so, it has been hypothesized that this association could be bidirectional, baseline frailty could turns out to be predictive of a deteriorated quality of life, just as a low quality of life at baseline could be a predictor of frailty at follow-up [37]. Our results appears to provide support for the first scenario, which means that a decreased functionality among frail OA affects their satisfaction in various areas (physical and social) that are measured with instruments such as the WHOQOL [12, 13, 37]. However, this association must be deeply explored in future longitudinal studies with older adults.

Related to frailty and mortality, our results were consistent with previous studies that have identified frailty is an independent predictor for death. A systematic review and meta-analysis of longitudinal studies with OA using the frailty phenotype, found that frail subjects had a risk of dying two times higher than non-frail subjects. Pre-frailty also increased the risk of death, although the association was weaker [38]. For older Mexican adults, this association was also reported by various studies. Specifically, Mexican Health and Aging Study (MHAS) and 10/66 Dementia Study found that frailty was a predictor for death [9, 39].

Observed association between the metabolic-vascular pattern and mortality, supports the reported evidence on the relationship between metabolic syndrome and the likelihood of die [40], although recently it has been suggested that this association can be mediated by factors such as frailty [41, 42] and sleep disorders [43]. Nevertheless, even controlling for frailty, disability and other variables, it has been found that the metabolic-vascular combination has an independent effect on survival rate among OA.

A secondary objective of this study was to evaluate the potential interaction effects of multimorbidity and frailty. Although we did not find a significant interaction between these conditions, evidence suggests that a causal connection could exist, given they share common physiopathological mechanisms [15]. Even so, few studies have explored the possibility of a combined effect. Among them, Woo et al. (2014) found that combination of frailty and multimorbidity increased the risk of disability and death in OA [16]. Future research with OA that deeply explore on different combinations of chronic conditions will help to understand the potential interaction of frailty and multimorbidity and their effects on diverse health outcomes.

The results of our study should be interpreted taking into account the following limitations. First, the analysis of multimorbidity was confined to the nine high burden chronic conditions utilized in SAGE; it did not include diseases such as chronic kidney failure, cancer, cardiac conditions and dyslipidemia, all prevalent in older Mexican adults. Nevertheless, various studies using larger, equal or lower number of CDs, have found similar multimorbidity patterns. Second, potential selection bias may have resulted from differences between the analytical sample and excluded OA. Respondents in the study proved somewhat more affluent than respondents excluded (see Additional file 2: Table S3), it is not clear how this could affect our results, although it is possible that people with a higher economic level have greater knowledge about their health status, and then our prevalence of multimorbidity patterns could be underestimated. If the above were true, then our associations could be somewhat biased.

Conclusion

Our findings are consistent with previous evidence about the effects of frailty and multimorbidity on disability, quality of life, and risk of death. These results highlight the importance of carrying out health promotion and prevention actions as well as specific interventions aimed at older adults who suffer from multimorbidity and frailty, in such a way that deleterious effects on health can be avoided. Although a potential interaction effect between frailty and multimorbidity was hypothesized, this association was not statistically significant.

Notes

Funding

SAGE is supported by WHO and the US National Institute on Aging through Interagency Agreements (OGHA04034785, YA1323–08-CN-0020, and Y1-AG-1005-01) and competitive grant: R01AG034479.

Availability of data and materials

The datasets analyzed during the current study are available in the WHO repository, [http://apps.who.int/healthinfo/systems/surveydata/index.php/catalog/sage/about].

Authors’ contributions

ARA, BME and ASR conceived and designed the study; ARA and ASR carried out the analysis; ARA, and ASR drafted the manuscript. All authors reviewed, edited, and contributed to rewriting of the manuscript. All the authors granted final approval to the version submitted for publication.

Ethics approval and consent to participate

Ethics and Research Committees of the National Institute of Public Health in Mexico approved the SAGE-Mexico Study. All participants were provided with a detailed explanation of study procedures and signed an informed consent letter.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary material

12877_2018_928_MOESM1_ESM.pptx (76 kb)
Additional file 1: Figure S1. Screeplot for multimorbidity patterns. Table S1. Eigenvectors values for the three multimorbidity patterns identified. (PPTX 75 kb)
12877_2018_928_MOESM2_ESM.docx (24 kb)
Additional file 2: Table S2. Interaction effects of multimorbidity patterns and frailty on disability, quality of life and mortality. Table S3. Observed differences between older adults included and excluded from the study. (DOCX 24 kb)

References

  1. 1.
    United Nations, Department of Economic and Social Affairs PD. World Population Prospects: The 2015 Revision, Key Findings and Advance Tables. 2015. Report No.: ESA/P/WP.241. Available from: https://esa.un.org/unpd/wpp/publications/files/key_findings_wpp_2015.pdf
  2. 2.
    Prince MJ, Wu F, Guo Y, Gutierrez Robledo LM, O’Donnell M, Sullivan R, et al. The burden of disease in older people and implications for health policy and practice. Lancet. 2015:549–62.CrossRefGoogle Scholar
  3. 3.
    Beard JR, Bloom DE. Towards a comprehensive public health response to population ageing. Lancet. 2015;385:658–61.CrossRefGoogle Scholar
  4. 4.
    Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011:430–9.CrossRefGoogle Scholar
  5. 5.
    Arokiasamy P, Uttamacharya U, Jain K, Biritwum RB, Yawson AE, Wu F, et al. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal? BMC Med. 2015;13.Google Scholar
  6. 6.
    Salive ME. Multimorbidity in older adults. Epidemiol Rev. 2013;35:75–83.CrossRefGoogle Scholar
  7. 7.
    Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, Van Den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014:254–66.CrossRefGoogle Scholar
  8. 8.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in Older Adults: Evidence for a Phenotype. Journals Gerontol Ser A Biol Sci Med Sci [Internet]. 2001;56:M146–57. Available from: https://academic.oup.com/biomedgerontology/article-lookup/doi/10.1093/gerona/56.3.M146 CrossRefGoogle Scholar
  9. 9.
    Aguilar-Navarro SG, Amieva H, Gutiérrez-Robledo LM, Avila-Funes JA. Frailty among Mexican community-dwelling elderly: a story told 11 years later. The Mexican health and aging study. Salud Publica Mex. 2015;57:S62–9.CrossRefGoogle Scholar
  10. 10.
    Vermeulen J, Neyens JC, Van Rossum E, Spreeuwenberg MD, De Witte LP. Predicting ADL disability in community-dwelling elderly people using physical frailty indicators: a systematic review. BMC Geriatr. 2011;11.Google Scholar
  11. 11.
    Shamliyan T, Talley KMC, Ramakrishnan R, Kane RL. Association of frailty with survival: a systematic literature review. Ageing Res Rev. 2013:719–36.CrossRefGoogle Scholar
  12. 12.
    Kojima G, Iliffe S, Morris RW, Taniguchi Y, Kendrick D, Skelton DA, et al. Frailty predicts trajectories of quality of life over time among British community-dwelling older people. Qual Life Res. 2016:1743–50.CrossRefGoogle Scholar
  13. 13.
    Moreno-Aguilar M, García-Lara JMA, Aguilar-Navarro S, Navarrete-Reyes AP, Amieva H, Avila-Funes JA. the Phenotype of Frailty and Health-Related Quality of Life. J Frailty Aging. 2013;2:1–6.Google Scholar
  14. 14.
    Kojima G. Frailty as a predictor of future falls among community-dwelling older people: a systematic review and meta-analysis. J Am Med Dir Assoc. 2015:1027–33.CrossRefGoogle Scholar
  15. 15.
    Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the Concepts of Disability, Frailty, and Comorbidity: Implications for Improved Targeting and Care. Journals Gerontol Ser A Biol Sci Med Sci [Internet]. 2004;59:M255–63. Available from: https://academic.oup.com/biomedgerontology/article-lookup/doi/10.1093/gerona/59.3.M255 CrossRefGoogle Scholar
  16. 16.
    Woo J, Leung J. Multi-morbidity, dependency, and frailty singly or in combination have different impact on health outcomes. Age (Omaha). 2014;36:923–31.CrossRefGoogle Scholar
  17. 17.
    Kowal P, Chatterji S, Naidoo N, Biritwum R, Fan W, Ridaura RL, et al. Data resource profile: the world health organization study on global ageing and adult health (SAGE). Int J Epidemiol. 2012;41:1639–49.CrossRefGoogle Scholar
  18. 18.
    Ustün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010;88:815–823. PMCID: PMC2971503. Available from: http://www.who.int/bulletin/volumes/88/11/09-067231/en/.CrossRefGoogle Scholar
  19. 19.
    Skevington SM, Lotfy M, O’Connell KA. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial a report from the WHOQOL group. Qual Life Res. 2004:299–310.CrossRefGoogle Scholar
  20. 20.
    Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M, et al. Global multimorbidity patterns: a cross-sectional, population-based, multi-country study. Journals Gerontol - Ser A Biol Sci Med Sci. 2016;71:205–14.CrossRefGoogle Scholar
  21. 21.
    Sin DD. Asthma-COPD overlap syndrome: what we know and what we don’t. Tuberc. Respir. Dis (Seoul). 2017;80:11–20.CrossRefGoogle Scholar
  22. 22.
    Rothnie KJ, Yan R, Smeeth L, Quint JK. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open. 2015.Google Scholar
  23. 23.
    Morley JE. The metabolic syndrome and aging. J Gerontol A Biol Sci Med Sci. 2004 [cited 2018 mar 21];59:139–42. Available from: https://academic.oup.com/biomedgerontology/article/59/2/M139/610275.CrossRefGoogle Scholar
  24. 24.
    Denys K, Cankurtaran M, Janssens W, Petrovic M. Metabolic syndrome in the elderly: an overview of the evidence. Acta Clin Belg. 2009;64:23–34.CrossRefGoogle Scholar
  25. 25.
    Von Korff M, Simon G. The relationship between pain and depression. Br J Psychiatry. 1996;168:101–8.CrossRefGoogle Scholar
  26. 26.
    Salazar A, Dueñas M, Ojeda B, Failde I. Association of painful musculoskeletal conditions and migraine headache with mental and sleep disorders among adults with disabilities, Spain, 2007–2008. Prev Chronic Dis. 2014;11:E30. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938964/.
  27. 27.
    Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003:2433–45.CrossRefGoogle Scholar
  28. 28.
    Jackson CA, Jones M, Tooth L, Mishra GD, Byles J, Dobson A. Multimorbidity patterns are differentially associated with functional ability and decline in a longitudinal cohort of older women. Age Ageing. 2015;44:810–6.CrossRefGoogle Scholar
  29. 29.
    Otiniano ME, Du XL, Ottenbacher K, Markides KS. The effect of diabetes combined with stroke on disability, self-rated health, and mortality in older Mexican Americans: Results from the Hispanic EPESE. Arch Phys Med Rehabil [Internet]. 2003;84:as0003999303049419. Available from: https://www.sciencedirect.com/science/article/pii/S0003999302049419?via%3Dihub.PubMedGoogle Scholar
  30. 30.
    Quiñones AR, Markwardt S, Botoseneanu A. Multimorbidity combinations and disability in older adults. Journals Gerontol - Ser A Biol Sci Med Sci. 2016;71:823–30.CrossRefGoogle Scholar
  31. 31.
    Avila-Funes JA, Medina-Campos RH, Tamez-Rivera O, Navarrete-Reyes AP, Amieva H, Aguilar-Navarro S. Frailty is associated with disability and recent hospitalization in community-dwelling elderly: the Coyoacan cohort. J frailty aging. 2014;3:206–10 Available from: http://www.ncbi.nlm.nih.gov/pubmed/27048858.PubMedGoogle Scholar
  32. 32.
    Papachristou E, Wannamethee SG, Lennon LT, Papacosta O, Whincup PH, Iliffe S, et al. Ability of self-reported frailty components to predict incident disability, falls, and all-cause mortality: results from a population-based study of older British men. J Am Med Dir Assoc. 2017;18:152–7.CrossRefGoogle Scholar
  33. 33.
    Makizako H, Shimada H, Doi T, Tsutsumimoto K, Suzuki T. Impact of physical frailty on disability in community-dwelling older adults: a prospective cohort study. BMJ Open. 2015;5.CrossRefGoogle Scholar
  34. 34.
    Cieza A, Sabariego C, Bickenbach J, Chatterji S. Rethinking Disability. BMC Med. 2018;16.Google Scholar
  35. 35.
    Sivertsen H, Bjørkløf GH, Engedal K, Selbæk G, Helvik AS. Depression and quality of life in older persons: a review. Dement Geriatr Cogn Disord. 2015:311–39.CrossRefGoogle Scholar
  36. 36.
    Senra H, Rogers H, Leibach G, Altamar MLP, Plaza SLO, Perrin P, et al. Health-related quality of life and depression in a sample of Latin American adults with rheumatoid arthritis. Int J Rheum Dis. 2014.Google Scholar
  37. 37.
    Kojima G, Iliffe S, Jivraj S, Walters K. Association between frailty and quality of life among community-dwelling older people: a systematic review and meta-analysis. J Epidemiol Community Health. 2016:716–21.CrossRefGoogle Scholar
  38. 38.
    Chang S-F, Lin P-L. Frail phenotype and mortality prediction: a systematic review and meta-analysis of prospective cohort studies. Int J Nurs Stud [Internet]. 2015;52:1362–74 Available from: http://linkinghub.elsevier.com/retrieve/pii/S0020748915001066.CrossRefGoogle Scholar
  39. 39.
    At J, Bryce R, Prina M, Acosta D, Ferri CP, Guerra M, et al. Frailty and the prediction of dependence and mortality in low- and middle-income countries: a 10/66 population-based cohort study. BMC Med. 2015;13:138.CrossRefGoogle Scholar
  40. 40.
    Forti P, Pirazzoli G. Metabolic syndrome and all-cause mortality in older men and women. Eur J. 2012;42:1000–9. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2362.2012.02688.x.CrossRefGoogle Scholar
  41. 41.
    Kane AE, Gregson E, Theou O, Rockwood K, Howlett SE. The association between frailty, the metabolic syndrome, and mortality over the lifespan. GeroScience. 2017;39:221–9.CrossRefGoogle Scholar
  42. 42.
    Hoogendijk EO, Huisman M, van Ballegooijen AJ. The role of frailty in explaining the association between the metabolic syndrome and mortality in older adults. Exp Gerontol. 2017;91:5–8.CrossRefGoogle Scholar
  43. 43.
    Fernandez-Mendoza J, He F, LaGrotte C, Vgontzas AN, Liao D, Bixler EO. Impact of the metabolic syndrome on mortality is modified by objective short sleep duration. J Am Heart Assoc. 2017;6.Google Scholar

Copyright information

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.National Institute of Public HealthCuernavacaMexico
  2. 2.Department of GeriatricsSalvador Zubirán National Institute of Medical Sciences and NutritionMexico CityMexico
  3. 3.Department of Health Statistics and Information Systems, World Health OrganizationGenevaSwitzerland
  4. 4.University of Newcastle Research Centre on Gender, Health and AgeingNewcastleAustralia
  5. 5.Chiang Mai University Research Institute for Health SciencesChiang MaiThailand

Personalised recommendations